Who has invested in Ocelot Bio?

RA Capital Management, Venrock, Vivo Capital are named among the investors backing Ocelot Bio.

Ocelot Bio Funding: $36M Raised, Series A (2022)

Ocelot Bio funding overview

Ocelot Bio has raised $36M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2022. The round record for Ocelot Bio runs through 2022; nothing later has been disclosed. Investors on record include RA Capital Management, Venrock, Vivo Capital. 3 distinct backers are named across the disclosed rounds.

Ocelot Bio at a glance

Total raised: $36M
Latest round: Series A
Latest round date: March 2022
Notable investors: RA Capital Management, Venrock, Vivo Capital

Frequently asked about Ocelot Bio funding

How much has Ocelot Bio raised?: Ocelot Bio has raised $36M in total disclosed funding across the rounds on record.
Who has invested in Ocelot Bio?: RA Capital Management, Venrock, Vivo Capital are named among the investors backing Ocelot Bio.
What was the latest Ocelot Bio funding round?: The most recent disclosed round is a Series A, announced in March 2022.
Where is Ocelot Bio based?: No headquarters location is disclosed for Ocelot Bio.
When did Ocelot Bio last raise?: The last disclosed Ocelot Bio round closed in March 2022 at Series A.

Every Ocelot Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies at a similar stage.

Ocelot Bio Funding: $36M Raised, Series A (2022)

Ocelot Bio funding overview

Ocelot Bio at a glance

Frequently asked about Ocelot Bio funding

Companies related to Ocelot Bio (18)

Browse related funding lists (6)